Literature DB >> 2917700

Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes.

A G Ziegler1, P Vardi, A T Ricker, M Hattori, J S Soeldner, G S Eisenbarth.   

Abstract

In an initial cross-sectional study, 29 female and 25 male nondiabetic weaned nonobese diabetic (NOD) mice of various ages (age range 30-300 days, mean 108 +/- 10 days) and 11 unweaned NOD pups were evaluated for competitive insulin autoantibodies (CIAAs) with a fluid-phase radioassay. Eleven of 54 (20%) weaned NOD mice had CIAA levels above the range (greater than 39 nU/ml) of 81 control mice. The group of NOD mice that progressed to diabetes had a significantly higher level of CIAAs than NOD mice that did not progress to diabetes (NOD mice progressing to diabetes: CIAA 63 +/- 12 nU/ml; NOD mice not progressing to diabetes: CIAA 8 +/- 4 nU/ml; P less than .02). Seven of 11 (64%) NOD mice having CIAA concentrations exceeding the normal range progressed to diabetes, whereas only 4 of 43 (9%) NOD mice progressed to diabetes without detection of elevated CIAAs (Fisher's exact test, P less than .0005). The relative risk of progressing to overt diabetes with CIAA levels greater than 39 nU/ml was therefore 17 (P less than .005), giving a positive predictive value of 64%, a negative predictive value of 91%, and an overall accuracy of 85%. None of 11 unweaned NOD pups had CIAA levels above the normal range (mean -9.4 +/- 4.9 nU/ml). At 6 wk of age, 37% of female NOD mice were CIAA+, whereas none of the male animals exceeded the normal range at this age (38 +/- 13 vs. 5 +/- 6 nU/ml, P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917700     DOI: 10.2337/diab.38.3.358

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  13 in total

1.  Enhanced trafficking to the pancreatic lymph nodes and auto-antigen presentation capacity distinguishes peritoneal B lymphocytes in non-obese diabetic mice.

Authors:  C Alam; S Valkonen; S Ohls; K Törnqvist; A Hänninen
Journal:  Diabetologia       Date:  2009-11-22       Impact factor: 10.122

2.  Transplantation analysis of B cell destruction in (NOD x CBA)F1 mouse bone marrow chimeras.

Authors:  D V Serreze; E H Leiter; L D Shultz
Journal:  Diabetologia       Date:  1990-02       Impact factor: 10.122

Review 3.  Autoantigens in type 1 diabetes mellitus.

Authors:  F Dotta; E Anastasi; C Tiberti; U Di Mario
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

4.  Insulin as a target antigen in autoimmune diabetes: a natural repertoire as the source of antibody response.

Authors:  K G Petersen; A N Khalaf; V Naithani; M Fabry; H Gattner
Journal:  Acta Diabetol       Date:  1994-06       Impact factor: 4.280

5.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes.

Authors:  L Yu; D T Robles; N Abiru; P Kaur; M Rewers; K Kelemen; G S Eisenbarth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 6.  100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Authors:  Anette-Gabriele Ziegler; Thomas Danne; Carolin Daniel; Ezio Bonifacio
Journal:  Med (N Y)       Date:  2021-09-15

7.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

Authors:  Z J Zhang; L Davidson; G Eisenbarth; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

8.  Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23).

Authors:  D Daniel; D R Wegmann
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-23       Impact factor: 11.205

9.  Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.

Authors:  J C Carel; P Bougnères; P Vardi
Journal:  J Endocrinol Invest       Date:  1994 Jul-Aug       Impact factor: 4.256

Review 10.  The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.

Authors:  James A Pearson; F Susan Wong; Li Wen
Journal:  J Autoimmun       Date:  2015-09-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.